@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP473983.RAHCBdqr428fMQwLz0DC0QDMmIrI90HG5UvCeHv0sSvJ8130_head { this: np:hasAssertion dgn-np:NP473983.RAHCBdqr428fMQwLz0DC0QDMmIrI90HG5UvCeHv0sSvJ8130_assertion; np:hasProvenance dgn-np:NP473983.RAHCBdqr428fMQwLz0DC0QDMmIrI90HG5UvCeHv0sSvJ8130_provenance; np:hasPublicationInfo dgn-np:NP473983.RAHCBdqr428fMQwLz0DC0QDMmIrI90HG5UvCeHv0sSvJ8130_publicationInfo; a np:Nanopublication . dgn-np:NP473983.RAHCBdqr428fMQwLz0DC0QDMmIrI90HG5UvCeHv0sSvJ8130_assertion a np:Assertion . dgn-np:NP473983.RAHCBdqr428fMQwLz0DC0QDMmIrI90HG5UvCeHv0sSvJ8130_provenance a np:Provenance . dgn-np:NP473983.RAHCBdqr428fMQwLz0DC0QDMmIrI90HG5UvCeHv0sSvJ8130_publicationInfo a np:PublicationInfo . } dgn-np:NP473983.RAHCBdqr428fMQwLz0DC0QDMmIrI90HG5UvCeHv0sSvJ8130_assertion { miriam-gene:3934 a ncit:C16612 . lld:C0856742 a ncit:C7057 . dgn-gda:DGN1fbc6cb0f34827bb01a9fe4afb473244 sio:SIO_000628 miriam-gene:3934, lld:C0856742; a sio:SIO_001121 . } dgn-np:NP473983.RAHCBdqr428fMQwLz0DC0QDMmIrI90HG5UvCeHv0sSvJ8130_provenance { dgn-np:NP473983.RAHCBdqr428fMQwLz0DC0QDMmIrI90HG5UvCeHv0sSvJ8130_assertion dcterms:description "[Our main findings were (i) patients with acute post-myocardial infarction (MI) HF (n = 236) and chronic HF (n = 150) had elevated serum levels of NGAL (determined by enzyme immunoassay), significantly correlated with clinical and neurohormonal deterioration, (ii) in patients with HF following acute MI, elevated NGAL levels of at baseline were associated with adverse outcomes (median of 27 months follow-up), (iii) in a rat model of post-MI HF, NGAL/lipocalin-2 gene expression was increased in the non-ischaemic part of the left ventricle primarily located to cardiomyocytes, (iv) strong NGAL immunostaining was found in cardiomyocytes within the failing myocardium both in experimental and clinical HF, (v) interleukin-1beta and agonists for toll-like receptors 2 and 4, representing components of the innate immune system, were potent inducers of NGAL/lipocalin-2 in isolated neonatal cardiomyocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:19329498; prov:wasDerivedFrom dgn-void:befree-20140225; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-20140225 pav:importedOn "2014-02-25"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP473983.RAHCBdqr428fMQwLz0DC0QDMmIrI90HG5UvCeHv0sSvJ8130_publicationInfo { this: dcterms:created "2014-10-02T12:36:44+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetrdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v2.1.0.0" . dgn-void:disgenetrdf pav:version "v2.1.0" . }